News & Updates

Beta-blockers reduce rosacea-related facial erythema, flushing

05 Oct 2020 by

Treatment with oral beta-blockers appears to be effective against rosacea-associated facial erythema and flushing that are nonresponsive to conventional therapy, suggests a study.

Beta-blockers reduce rosacea-related facial erythema, flushing

05 Oct 2020

First-line chemo plus necitumumab improves overall survival in advanced NSCLC

05 Oct 2020

Adding necitumumab to standard chemotherapy in a first-line setting significantly improves overall survival in patients with stage IV nonsmall cell lung cancer (NSCLC), a study has shown. However, results for progression-free survival (PFS) and objective response rate (ORR) are not statistically significant.

First-line chemo plus necitumumab improves overall survival in advanced NSCLC

05 Oct 2020

Sustained-release morphine may benefit patients with COPD

05 Oct 2020 by

Regular, low-dose, oral sustained-release morphine improved the health status of patients with moderate-to-very-severe chronic breathlessness due to chronic obstructive pulmonary disease (COPD), the MORDYC* trial has shown, validating its palliative role for chronic breathlessness.

Sustained-release morphine may benefit patients with COPD

05 Oct 2020

Comorbidities flag poor outcome on vedolizumab, ustekinumab for IBD

05 Oct 2020

In the treatment of patients with inflammatory bowel disease (IBD), comorbidities, but not patient age, influence the risk of any infection or hospitalizations on either vedolizumab or ustekinumab, a study suggests.

Comorbidities flag poor outcome on vedolizumab, ustekinumab for IBD

05 Oct 2020

Lorecivivint for knee OA unsuccessful in phase IIa trial

05 Oct 2020

The novel Wnt pathway modulator lorecivivint does not appear to be effective for treating pain and inhibiting structural progression in moderate-to-severe knee osteoarthritis (OA), according to the results of a phase IIa trial.

Lorecivivint for knee OA unsuccessful in phase IIa trial

05 Oct 2020

Obesity not a reason for aggressive levofloxacin dosing for febrile neutropaenia prophylaxis

04 Oct 2020

Obesity does not appear to be strongly correlated with an increased risk for febrile neutropaenia during levofloxacin prophylaxis in patients with haematological malignancies receiving intermediate-risk myelosuppressive chemotherapy, suggests a study.

Obesity not a reason for aggressive levofloxacin dosing for febrile neutropaenia prophylaxis

04 Oct 2020

Turmeric for pain relief in knee OA?

03 Oct 2020 by

Turmeric extract supplements can help reduce knee pain associated with knee osteoarthritis, although there are no changes in knee effusion-synovitis or cartilage composition, a study suggests.

Turmeric for pain relief in knee OA?

03 Oct 2020

REPLENISH: Hormone pill for vasomotor symptoms delivers no substantial effect on weight, BP

03 Oct 2020 by

Use of a single-capsule 17β-estradiol (E2)/progesterone (P4) to treat vasomotor symptoms does not appear to produce unwanted changes in body weight and blood pressure (BP) in postmenopausal women, according to data from the phase III REPLENISH trial.

REPLENISH: Hormone pill for vasomotor symptoms delivers no substantial effect on weight, BP

03 Oct 2020

Asymptomatic COVID-19 patients shed virus for longer period

02 Oct 2020 by

Not only do asymptomatic COVID-19 carriers have viral loads that are similar to symptomatic patients, they could remain asymptomatic for a prolonged period of median 24 days from diagnosis, reveals a study.

Asymptomatic COVID-19 patients shed virus for longer period

02 Oct 2020

Radiotherapy with concurrent docetaxel beneficial in seniors with oesophageal cancer

02 Oct 2020

Radiotherapy with concurrent docetaxel is safe and effective in elderly patients with oesophageal cancer, regardless of baseline renal function, according to a study.

Radiotherapy with concurrent docetaxel beneficial in seniors with oesophageal cancer

02 Oct 2020

News & Updates

Filter by Specialty:

Specialty:

Beta-blockers reduce rosacea-related facial erythema, flushing

Beta-blockers reduce rosacea-related facial erythema, flushing

First-line chemo plus necitumumab improves overall survival in advanced NSCLC

First-line chemo plus necitumumab improves overall survival in advanced NSCLC

Sustained-release morphine may benefit patients with COPD

Sustained-release morphine may benefit patients with COPD

Comorbidities flag poor outcome on vedolizumab, ustekinumab for IBD

Comorbidities flag poor outcome on vedolizumab, ustekinumab for IBD

Lorecivivint for knee OA unsuccessful in phase IIa trial

Lorecivivint for knee OA unsuccessful in phase IIa trial

Obesity not a reason for aggressive levofloxacin dosing for febrile neutropaenia prophylaxis

Obesity not a reason for aggressive levofloxacin dosing for febrile neutropaenia prophylaxis

Turmeric for pain relief in knee OA?

Turmeric for pain relief in knee OA?

REPLENISH: Hormone pill for vasomotor symptoms delivers no substantial effect on weight, BP

REPLENISH: Hormone pill for vasomotor symptoms delivers no substantial effect on weight, BP

Asymptomatic COVID-19 patients shed virus for longer period

Asymptomatic COVID-19 patients shed virus for longer period

Radiotherapy with concurrent docetaxel beneficial in seniors with oesophageal cancer

Radiotherapy with concurrent docetaxel beneficial in seniors with oesophageal cancer